Sponsor:
Sanofi
Code:
NCT06676319
Conditions
Asthma
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Lunsekimig
Short-Acting Beta Agonists (SABA)
Placebo
Fluticasone/salmeterol
Budesonide/formoterol
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-20. This information was provided to ClinicalTrials.gov by Sanofi on 2025-05-21.